NanoViricides Inc. (NNVC)

[keltoi]

Just so you know it wasn't me calling the SEC either.Also I got the grant info by calling Sen.Lieberman's office and asked them to track the grant progress.Also of interest (you mentioned Novartis) is that all the other "competition" is developing meds that attack the virus in question , after it has invaded the target cell.That is what causes patient side effects due to the body's immune response being triggered.Their drugs will be more difficult to get through the FDA and will lose effectiveness like Tamiflu as the virus mutates.NNVC , however operates in the bloodstream and attacks the virus BEFORE it invades the target cells and is then flushed out of the body.This eliminates toxicity , side effects and immune response triggers.Remember also , Novartis and others have to develop a drug for each specific virus type and get it through the FDA one at a time.NNVC , on the other hand , only has to get it's "Platform" through the FDA for one disease as all the other virus cures use the same platform , just different protein receptors.Also , a virus can't mutate around NNVC because if it did it would lose it's ability to attach to the target cells making it impotent from the start.